I agree that CRs dilute ones holding in the company if not taken up but on the flip side the company should be using the funds to add to the asset base of the company along the way. This is as true for biotechs like AHZ as it is for the mining companies in the exploration phase.
hsv2 final results, page-77
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.64 |
Change
-0.360(2.40%) |
Mkt cap ! $311.5M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.00 | $14.50 | $33.87K | 2.304K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 115 | $14.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.64 | 216 | 2 |
View Market Depth
| Last trade - 11.33am 15/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |